Furthermore, NODAL signaling activity is maintained by ZIC3. We detected considerably higher levels of these NODAL signaling keyplayers in ECs compared to CIS /seminomas (Fig 5A). This evidence concerns the gene ZIC3 and in situ carcinoma.